close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

71.49 +0.59 (+0.83%)
Streaming Delayed Price Updated: 12:46 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
GeneDx Holdings (NASDAQ:WGS) Beats Q2 Revenue Estimates and Swings to Adjusted Profit ↗
Via Chartmill
News headline image
GeneDx Q2 Earnings Call Highlights ↗
GeneDx (NASDAQ:WGS) reported second-quarter revenue of $114.4 million, above its prior guidance, as exome and genome testing volume reached a quarterly record of more than 30,000 tests. The company... 
Via MarketBeat
Topics Earnings
News headline image
What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17% ↗
GeneDx leverages AI-driven analytics for healthcare insights; a key insider recently trimmed their stake, according to SEC filings. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Hedge Funder Eli Casdin Is Loading up on GeneDx Shares ↗
GeneDx Holdings, known for AI-driven health data, reported a notable insider buy amid continued momentum in precision medicine services. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
GeneDx Holdings Corp (NASDAQ:WGS) Plunges 44% After Disastrous Q1 2026 Miss ↗
Via Chartmill
GeneDx Holdings Corp (NASDAQ:WGS) Reports Mixed Q4 2025 Results, Stock Falls Despite Strong 2026 Outlook ↗
Via Chartmill
News headline image
From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading ↗
Check out these three stocks that insiders are buying and selling, including giants in oil and AI, as well as a small gene stock seeing huge swings. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares? ↗
AI-driven health intelligence provider GeneDx attracted a notable insider buy, as recent filings highlight activity amid a volatile year. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
One of these stocks plummeted 49% on Tuesday. 
Via The Motley Fool
Topics Initial Public Offering
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
News headline image
Why GeneDX Stock Is Plummeting Today ↗
GeneDX's latest quarterly report arrived with a lot of bad news for investors. 
Via The Motley Fool
Which stocks are gapping on Tuesday? ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
GeneDx (WGS) Q1 2026 Earnings Transcript ↗
GeneDx (WGS) Q1 2026 Earnings Transcript 
Via The Motley Fool
Top movers in Monday's after hours session ↗
Via Chartmill
News headline image
GeneDx (WGS) Q1 2025 Earnings Call Transcript ↗
GeneDx (WGS) Q1 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
GeneDx (WGS) Q2 2025 Earnings Transcript ↗
GeneDx (WGS) Q2 2025 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Three stocks that have fallen more than 23% this year were on the Ark Invest CEO's shopping radar on Tuesday. 
Via The Motley Fool
Topics ETFs
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
Ark Invest's CEO kicked off the new trading week with a little shopping. 
Via The Motley Fool
News headline image
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million ↗
Relay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What a $75 Million Exit From MDU Might Signal Amid a 24% One-Year Rally ↗
MDU Resources Group supplies regulated utilities and construction services across the U.S., with consistent revenue and a stable dividend. 
Via The Motley Fool
Topics Energy
News headline image
GeneDx's Chief Operating Officer Sold Nearly 6,000 Shares. Is the Stock a Buy or Sell? ↗
AI-powered health intelligence firm GeneDx Holdings reported a notable insider sale as it advances its clinical data analytics platform. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
GeneDx (WGS) Q4 2025 Earnings Call Transcript ↗
GeneDx (WGS) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗
Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets. 
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗
This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year ↗
Air Lease Corporation provides global airlines with commercial jet leasing, sales, and fleet management services across a diverse portfolio. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy ↗
Five9 delivers cloud-based contact center software for enterprises, serving clients across finance, healthcare, and technology sectors. 
Via The Motley Fool
News headline image
Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares ↗
Freshworks delivers cloud-based SaaS solutions for customer engagement, IT service management, and business process automation. 
Via The Motley Fool
Topics Regulatory Compliance
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.